Uncovering the genetic architecture of major depression

AM McIntosh, PF Sullivan, CM Lewis - Neuron, 2019 - cell.com
There have been several recent studies addressing the genetic architecture of depression.
This review serves to take stock of what is known now about the genetics of depression, how …

Results of the European Group for the Study of Resistant Depression (GSRD)—basis for further research and clinical practice

L Bartova, M Dold, A Kautzky, C Fabbri… - The World Journal of …, 2019 - Taylor & Francis
Objectives: The overview outlines two decades of research from the European Group for the
Study of Resistant Depression (GSRD) that fundamentally impacted evidence-based …

Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts

C Fabbri, SP Hagenaars, C John, AT Williams… - Molecular …, 2021 - nature.com
Abstract Treatment-resistant depression (TRD) is a major contributor to the disability caused
by major depressive disorder (MDD). Primary care electronic health records provide an …

[HTML][HTML] Identifying the common genetic basis of antidepressant response

O Pain, K Hodgson, V Trubetskoy, S Ripke… - … psychiatry global open …, 2022 - Elsevier
Background Antidepressants are a first-line treatment for depression. However, only a third
of individuals experience remission after the first treatment. Common genetic variation, in …

Predicting patients who will drop out of out-patient psychotherapy using machine learning algorithms

B Bennemann, B Schwartz, J Giesemann… - The British Journal of …, 2022 - cambridge.org
Background About 30% of patients drop out of cognitive–behavioural therapy (CBT), which
has implications for psychiatric and psychological treatment. Findings concerning drop out …

Genetic underpinnings of sociability in the general population

J Bralten, NR Mota, CJHM Klemann… - …, 2021 - nature.com
Levels of sociability are continuously distributed in the general population, and decreased
sociability represents an early manifestation of several brain disorders. Here, we …

Different responses to risperidone treatment in Schizophrenia: a multicenter genome-wide association and whole exome sequencing joint study

M Zhao, J Ma, M Li, W Zhu, W Zhou, L Shen… - Translational …, 2022 - nature.com
Risperidone is routinely used in the clinical management of schizophrenia, but the treatment
response is highly variable among different patients. The genetic underpinnings of the …

Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder

G Fanelli, F Benedetti, S Kasper, J Zohar… - Progress in Neuro …, 2021 - Elsevier
Up to 60% of patients with major depressive disorder (MDD) do not respond to the first
treatment with antidepressants. Response to antidepressants is a polygenic trait, although …

Exome-wide association study of treatment-resistant depression suggests novel treatment targets

SB Shah, TN Peddada, C Song, M Mensah, H Sung… - Scientific Reports, 2023 - nature.com
Abstract Treatment-resistant depression (TRD) is a severe form of major depressive disorder
(MDD) with substantial public health impact and poor treatment outcome. Treatment …

[HTML][HTML] Predictors and risk factors of treatment-resistant depression: A systematic review

SJ O'Connor, N Hewitt, J Kuc… - The Journal of Clinical …, 2023 - psychiatrist.com
Objective: To systematically review the literature to identify and categorize the predictors and
risk factors for treatment-resistant depression (TRD). Data Sources: Online databases …